Nektar Therapeutics company logo
Nektar Therapeutics logo

Nektar Therapeutics (NKTR) EBITDA

Annual EBITDA

-$86.70M$156.41M+64.34%

Summary

Current Value
As of today, NKTR annual EBITDA is -$86.70M, up +64.34% on
Historical Performance
NKTR annual EBITDA is up +81.23% over the past 3 years, and up +77.22% over the past 5 years
All-Time High Comparison
NKTR annual EBITDA is currently -111.77% below its historical high of $736.37M set on
3-Year Low Comparison
NKTR annual EBITDA is +73.16% above its 3-year low of -$323.04M reached on an earlier date
Sector Comparison
NKTR annual EBITDA is higher than 19.67% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

NKTR Performance
MetricDateValue1Y3Y5Y15Y
-$86.70M+64.3%+81.2%+77.2%-14.5%
-$31.34M+5.9%+9.9%+68.6%-1421.2%
-$135.20M-3.9%+55.0%+63.1%-4471.0%
Price$36.90+251.4%-20.4%-87.8%-77.8%
-
$98.43M+9.2%-3.4%-14.1%+36.8%
-$8.68-497.2%-203.6%-244.6%-681.7%
Annual EBIT-$91.09M+63.7%+80.9%+76.9%-0.5%
-$118.96M+56.9%+77.3%+73.0%-16.0%

EBITDA Highs

NKTR Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y-$86.70Mat high
5Y-$86.70Mat high
All$736.37M-111.8%

EBITDA Lows

NKTR Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y-$323.04MN/A+73.2%
5Y-$461.82M+81.2%
All-$461.82M+81.2%

EBITDA History

YearValueChange
-$86.70M+64.3%
-$243.11M+24.7%
-$323.04M+30.1%
-$461.82M-17.6%
-$392.65M-3.2%
-$380.54M-151.7%
$736.37M+1,923.6%
-$40.38M+57.5%
-$95.12M-229.0%
-$28.92M-953.8%
-$2.74M+97.4%
-$104.73M+15.1%
-$123.40M-14.5%
-$107.79M-1,055.0%
-$9.33M+87.7%
-$75.72M-3,082.1%
YearValueChange
$2.54M+135.7%
-$7.12M+94.3%
-$125.72M+15.4%
-$148.54M-171.3%
-$54.76M-14.6%
-$47.77M+41.1%
-$81.11M-15.4%
-$70.32M-30.9%
-$53.72M-130.2%
-$23.34M-26.9%
-$18.39M-63.0%
-$11.29M-9.6%
-$10.30M-33.8%
-$7.70M-48.1%
-$5.20M-

FAQ

  • What is the current annual EBITDA of NKTR?

    As of today, NKTR annual EBITDA is -$86.70M

  • What is 1-year change in NKTR annual EBITDA?

    NKTR annual EBITDA is up +64.34% year-over-year

  • What is 3-year change in NKTR annual EBITDA?

    NKTR annual EBITDA is up +81.23% over the past 3 years

  • How far is NKTR annual EBITDA from its all-time high?

    NKTR annual EBITDA is currently -111.77% below its historical high of $736.37M set on December 31, 2018

  • How does NKTR annual EBITDA rank versus sector peers?

    NKTR annual EBITDA is higher than 19.67% of companies in Healthcare sector

  • When is NKTR next annual earnings release?

    The next annual earnings release for NKTR is on

EBITDA Formula

EBITDA = + + +

Data Sources & References

  1. NKTR Official Website www.nektar.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/906709/000119312525270230/0001193125-25-270230-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/906709/000095017025039389/0000950170-25-039389-index.htm
  4. NKTR Profile on Yahoo Finance finance.yahoo.com/quote/NKTR
  5. NKTR Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nktr